Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.

<h4>Aims</h4>ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further characterize this transgenic str...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikolett Lénárt, Viktor Szegedi, Gábor Juhász, Aniko Kasztner, János Horváth, Erika Bereczki, Melinda E Tóth, Botond Penke, Miklós Sántha
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/50388ac2af4d4398862f55cad7d2d37b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:50388ac2af4d4398862f55cad7d2d37b
record_format dspace
spelling oai:doaj.org-article:50388ac2af4d4398862f55cad7d2d37b2021-11-18T07:04:16ZIncreased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.1932-620310.1371/journal.pone.0046007https://doaj.org/article/50388ac2af4d4398862f55cad7d2d37b2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23029362/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Aims</h4>ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further characterize this transgenic strain in order to reveal a possible link between hypeprlipidemia and neurodegeneration.<h4>Methods and results</h4>We analyzed the serum and cerebral lipid profiles, tau phosphorylation patterns, amyloid plaque-formation, neuronal apoptosis and synaptic plasticity of young (3 month old), adult (6 month old) and aging (10-11 month old) transgenic mice. We show that ApoB-100 transgenic animals present i) elevated serum and cerebral levels of triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser(199), Ser(199/202), Ser(396) and Ser(404). Furthermore, we demonstrate, that tau hyperphosphorylation is accompanied by impaired presynaptic function, long-term potentiation and widespread hippocampal neuronal apoptosis.<h4>Conclusions</h4>The results presented here indicate that elevated ApoB-100 level and the consequent chronic hypertriglyceridemia may lead to impaired neuronal function and neurodegeneration, possibly via hyperphosphorylation of tau protein. On account of their specific phenotype, ApoB-100 transgenic mice may be considered a versatile model of hyperlipidemia-induced age-related neurodegeneration.Nikolett LénártViktor SzegediGábor JuhászAniko KasztnerJános HorváthErika BereczkiMelinda E TóthBotond PenkeMiklós SánthaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e46007 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nikolett Lénárt
Viktor Szegedi
Gábor Juhász
Aniko Kasztner
János Horváth
Erika Bereczki
Melinda E Tóth
Botond Penke
Miklós Sántha
Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
description <h4>Aims</h4>ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further characterize this transgenic strain in order to reveal a possible link between hypeprlipidemia and neurodegeneration.<h4>Methods and results</h4>We analyzed the serum and cerebral lipid profiles, tau phosphorylation patterns, amyloid plaque-formation, neuronal apoptosis and synaptic plasticity of young (3 month old), adult (6 month old) and aging (10-11 month old) transgenic mice. We show that ApoB-100 transgenic animals present i) elevated serum and cerebral levels of triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser(199), Ser(199/202), Ser(396) and Ser(404). Furthermore, we demonstrate, that tau hyperphosphorylation is accompanied by impaired presynaptic function, long-term potentiation and widespread hippocampal neuronal apoptosis.<h4>Conclusions</h4>The results presented here indicate that elevated ApoB-100 level and the consequent chronic hypertriglyceridemia may lead to impaired neuronal function and neurodegeneration, possibly via hyperphosphorylation of tau protein. On account of their specific phenotype, ApoB-100 transgenic mice may be considered a versatile model of hyperlipidemia-induced age-related neurodegeneration.
format article
author Nikolett Lénárt
Viktor Szegedi
Gábor Juhász
Aniko Kasztner
János Horváth
Erika Bereczki
Melinda E Tóth
Botond Penke
Miklós Sántha
author_facet Nikolett Lénárt
Viktor Szegedi
Gábor Juhász
Aniko Kasztner
János Horváth
Erika Bereczki
Melinda E Tóth
Botond Penke
Miklós Sántha
author_sort Nikolett Lénárt
title Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
title_short Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
title_full Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
title_fullStr Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
title_full_unstemmed Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.
title_sort increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic apob-100 transgenic mice.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/50388ac2af4d4398862f55cad7d2d37b
work_keys_str_mv AT nikolettlenart increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT viktorszegedi increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT gaborjuhasz increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT anikokasztner increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT janoshorvath increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT erikabereczki increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT melindaetoth increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT botondpenke increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
AT miklossantha increasedtauphosphorylationandimpairedpresynapticfunctioninhypertriglyceridemicapob100transgenicmice
_version_ 1718423975605829632